A single blinded randomised, crossover, individual comparison on cardiac performance of xenon vs. sevoflurane inhalation in humans undergoing coronary artery bypass grafting

• Conditions: CABG; 10011082

• Registration Number: NL-OMON31231
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Age range: 18 years and older, Patients who have to undergo elective cardiac surgery (CABG with or without valve surgery), Written informed consent

Exclusion Criteria

Age range: < 18 years, Emergency operations, Pregnancy, Severe COPD, Informed written consent missing, SaO2 < 90% (room atmosphere), Presumed non-cooperatives, Legal incapacity, Any clinical condition which does not justify study participation in the investigator's opinion

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is defined as the change in cardiac performance, defined<br /><br>as cardiac function index (PICCO) and contractility index (TEE).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>